You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 29, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Basant Malik1, Amit K Goyal, T S Markandeywar
1Nanomedicine Research Centre, Department of Pharmaceutics, Indo-Soviet Friendship College of Pharmacy, Moga, Punjab, India.
Novel M-cell targeted nanoparticles offer enhanced oral antigen delivery, protecting against gastric conditions. These Ulex europaeus agglutinin (UEA-1) lectin-coated particles effectively stimulate both systemic and mucosal immunity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: